Regulators in the US have approved the first official trial for the use of human embryonic stem cells in patients.

Science correspondent Tom Feilden explains the potential of stem-cell treatments.

And professor of regenerative medicine Chris Mason outlines the importance of these trials.

Get in touch with Today via email , Twitter or Facebook or text us on 84844.